CVS Health Corporation (CVS)
| Market Cap | 105.38B |
| Revenue (ttm) | 391.69B |
| Net Income (ttm) | 469.00M |
| Shares Out | 1.27B |
| EPS (ttm) | 0.37 |
| PE Ratio | 223.90 |
| Forward PE | 12.07 |
| Dividend | $2.66 (3.20%) |
| Ex-Dividend Date | Jan 22, 2026 |
| Volume | 7,591,500 |
| Open | 82.33 |
| Previous Close | 82.68 |
| Day's Range | 81.99 - 83.29 |
| 52-Week Range | 52.69 - 85.15 |
| Beta | 0.48 |
| Analysts | Strong Buy |
| Price Target | 92.11 (+10.96%) |
| Earnings Date | Feb 10, 2026 |
About CVS
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for CVS stock is "Strong Buy." The 12-month stock price target is $92.11, which is an increase of 10.96% from the latest price.
News
CVS Health supports communities as major winter storm approaches
Pharmacy patients encouraged to pick up prescriptions before conditions deteriorate WOONSOCKET, R.I., Jan. 23, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for the major winter s...
Health insurance executives pressed on affordability in Congress
Top executives from five of the nation's largest health insurers began testifying on Thursday to lawmakers in both the U.S. House of Representatives and Senate about the rising costs of Americans' hea...
CVS Health® makes health insurance simpler and more affordable for Americans
HARTFORD, Conn., Jan. 22, 2026 /PRNewswire/ -- CVS Health® today announced key milestones in its ongoing effort to make health care simpler and more affordable for American consumers.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
UNH Stock vs. CVS
UnitedHealth‘s stock has significantly lagged behind competitors like CVS and Centene over the previous year. A detailed examination indicates strong profitability, with an LTM Operating Margin of 6%,...
CVS Health to hold fourth quarter and full year 2025 earnings conference call
WOONSOCKET, R.I., Jan. 15, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Tuesday, February 10th, 2026, at 8:00 a.m.
CVS Health Foundation Grants the American Diabetes Association $2.6 Million to Expand Maternal Diabetes Program Across Two Additional NYC Communities
Building on 18 months of proven success, the initiative will scale evidence-based solutions to improve pregnancy and postpartum outcomes for New Yorkers NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The CVS...
Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO Daniel O'Day said at a major industry conference that kicked off on Monday in Sa...
Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are
A new report from Hunterbrook Media investigates how the three biggest health care giants in the U.S.— CVS Health Corp. (NASDAQ:CVS), UnitedHealth Group, Inc. (NYSE:UNH) and Cigna Group (NYSE:CI) — ar...
CVS Health declares quarterly dividend
WOONSOCKET, R.I., Jan. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per sh...
These Healthcare and Bank Stocks Had Incredible Runs in 2025. Why Gains Will Continue This Year.
With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Codoxo's Oversubscribed Series C Led by CVS Health Ventures to Revolutionize Payment Integrity for America's Largest Health Plans
DULUTH, Ga.--(BUSINESS WIRE)--Codoxo, the leading provider of AI and generative AI-powered healthcare payment integrity solutions, raised $35M in Series C funding, led by CVS Health Ventures. Echo Hea...
Final Trade: ETH, GM, CVS, NFLX
The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.
Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors
Chewy Inc. gained 12% during the quarter as the company delivered solid results driven by higher autoship subscription activity and expanding private-label offerings. The largest contributors to Fund ...
Top Wall Street analysts are upbeat on these 3 dividend stocks for enhanced returns
TipRanks' ranking service discusses three dividend-paying stocks, including Devon Energy and CVS Health.
The consumer is frustrated right now, says CVS Health CEO David Joyner
CNBC's Jim Cramer sits down with CVS Health CEO David Joyner to discuss the company's investor day, how healthcare technology is changing, the role of artificial intelligence and more.
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Unvaccinated residents can receive a measles vaccine at select CVS Pharmacy and MinuteClinic locations across the state WOONSOCKET, R.I. , Dec. 11, 2025 /PRNewswire/ -- As South Carolina public health...
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript
CVS Health Corporation (CVS) Analyst/Investor Day Prepared Remarks Transcript
Cramer's Stop Trading: CVS Health
CNBC's Jim Cramer explains why he is keeping an eye on shares of CVS Health.
Buy Or Fear CVS Stock At $78?
CVS Health's (NYSE: CVS) latest results affirm several points: their sales and adjusted profits remain stable, and they are adjusting their forecasts upward. Nonetheless, the quality of their profits ...
CVS Health Hikes Its Outlook, and Says It Plans to Roll Out AI Platform
CVS wants investors to know it sees bigger profits ahead, and has new AI plans.
CVS Health: Investor Day Targets Set Attractive Baseline For 2026
CVS Health is positioned for continued outperformance, with a strong turnaround driving industry-leading results and a reiterated "Buy" rating. CVS's Q3 showed 7.8% revenue growth, 47% adjusted EPS gr...
Jim Cramer says CVS stock may be the only first-class healthcare name we have
Famed investor Jim Cramer says he “salutes” DaviCVSd Joyner after CVS Health (NYSE: CVS) raised its profit guidance for 2026 – reinforcing the new management's turnaround plan is starting to bear frui...